Table 2.

Efficacy of IST according to selected observational studies

StudyNMedian age, yPartial remissionComplete remission
EACH2 registry26  294 75 NR GC: 58%
GC + Cy: 80%
GC + Ri: 64% 
GTH-AH 01/201012  102 74 83% 61% 
Spanish registry14  151 74 NR 84% 
Dutch cohort study13  143 73 NR 79% 
Chinese national registry27  187 52 GC: 70%
GC + Cy: 92% 
GC: 49%
GC + Cy: 83% 
Budapest (CyDRi)20  32 77 NR 91% 
StudyNMedian age, yPartial remissionComplete remission
EACH2 registry26  294 75 NR GC: 58%
GC + Cy: 80%
GC + Ri: 64% 
GTH-AH 01/201012  102 74 83% 61% 
Spanish registry14  151 74 NR 84% 
Dutch cohort study13  143 73 NR 79% 
Chinese national registry27  187 52 GC: 70%
GC + Cy: 92% 
GC: 49%
GC + Cy: 83% 
Budapest (CyDRi)20  32 77 NR 91% 

Cy, cyclophosphamide; GC, glucocorticoid; NR, not reported; Ri, rituximab.

or Create an Account

Close Modal
Close Modal